Mainz Biomed B.V.

NASDAQ:MYNZ

2.55 (USD) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -21.651-26.296-26.387-11.69-0.587-0.957
Depreciation & Amortization 1.0170.8660.380.070.060.053
Deferred Income Tax 000000
Stock Based Compensation 1.1364.0069.8246.4300
Change In Working Capital 0.052-0.065-0.437-0.1390.0580.423
Accounts Receivables 0.0640.016-0.2110.024-0.0990.34
Inventory 0.03-0.5-0.172-670.725-0.160
Accounts Payables 00.720670.7250.160
Other Working Capital -0.042-0.3-0.054-0.1630.1570.083
Other Non Cash Items 2.355-0.4511.8512.10800.064
Operating Cash Flow -17.09-21.939-14.77-3.22-0.469-0.416
Investing Activities:
Investments In Property Plant And Equipment -0.105-1.199-0.658-0.017-0.010
Acquisitions Net 0.033001.2200
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites -0.127-0.701.2200
Investing Cash Flow -0.199-1.899-0.6581.203-0.010
Financing Activities:
Debt Repayment 3.137.834-0.1980.1850.3710.424
Common Stock Issued 13.7656.393010.42500
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities -0.295024.14100.0250
Financing Cash Flow 16.614.22723.94310.6110.3970.424
Other Information:
Effect Of Forex Changes On Cash -0.146-0.46-0.1010.0120.001-0.033
Net Change In Cash -0.835-10.0718.4148.605-0.081-0.026
Cash At End Of Period 6.2367.07117.1428.7280.1230.204